DL-alpha-Methylphenethylamine
Categoria
DL-alpha-Methylphenethylamine Nombres de marca, DL-alpha-Methylphenethylamine Analogos
- (+/-)-Benzedrine
- (+/-)-Desoxynorephedrine
- (+/-)-beta-Phenylisopropylamine
- 1-Methyl-2-phenylethylamine
- 1-Phenyl-2-aminopropane
- 3-Methoxy-a-methylbenzeneethanamine
- 3-Methoxyamphetamine
- 3-Methoxyphenylisopropylamine
- Actedron
- Adipan
- Allodene
- Amphetamine (Narcotics)
- Amphetamine Sulfate
- Anorexide
- Anorexine
- Benzebar
- Benzedrine
- Benzolone
- DL-alpha-Methylphenethylamine
- Desoxyn
- Dexampex
- Dexedrine
- Dextroamphetamine Sulfate
- Dextrostat
- Elastonon
- Fenamin
- Fenylo-izopropylaminyl
- Ferndex
- Finam
- Isoamycin
- Isoamyne
- Isomyn
- Mecodrin
- Methampex
- Methamphetamine HCL
- Norephedrane
- Norephedrine, deoxy-
- Novydrine
- Oktedrin
- Ortedrine
- Paredrine
- Percomon
- Phenamine
- Phenedrine
- Phenylisopropylamine
- Profamina
- Propisamine
- Psychedrine
- Raphetamine
- Rhinalator
- Simpatedrin
- Simpatina
- Sympamin
- Sympamine
- Sympatedrine
- Weckamine
- [1-(3-Methoxyphenyl)-2-propyl]amine
- alpha-Methylbenzeneethaneamine
- amphetamine base
- beta-Aminopropylbenzene
- dl-1-Phenyl-2-aminopropane
- dl-Amphetamine
- dl-Benzedrine
- m-Methoxy-a-methylphenethylamine
- m-Methoxyamphetamine
- racemic-Desoxynor-ephedrine
DL-alpha-Methylphenethylamine Marca los nombres de mezcla
DL-alpha-Methylphenethylamine Formula quimica
C9H13N
DL-alpha-Methylphenethylamine RX enlace
http://www.rxlist.com/cgi/generic3/adderallxr.htm
DL-alpha-Methylphenethylamine FDA hoja
DL-alpha-Methylphenethylamine MSDS (hoja de seguridad de materiales)
DL-alpha-Methylphenethylamine Sintesis de referencia
Patente de EE.UU.. 1879003, (1932)
DL-alpha-Methylphenethylamine Peso molecular
135.206 g/mol
DL-alpha-Methylphenethylamine Punto de fusion
Volatizes slowly at room temperature
DL-alpha-Methylphenethylamine H2O Solubilidad
Ligeramente
DL-alpha-Methylphenethylamine Estado
Solid
DL-alpha-Methylphenethylamine LogP
1.799
DL-alpha-Methylphenethylamine Formas de dosificacion
Cápsulas
DL-alpha-Methylphenethylamine Indicacion
Para el tratamiento del Trastorno de Déficit de Atención con Hiperactividad (TDAH) y la narcolepsia en niños.
DL-alpha-Methylphenethylamine Farmacologia
La anfetamina y la dextroanfetamina, no catechloamine agentes sypathomimetic, se utilizan en combinación para tratar el déficit de atención con hiperactividad (TDAH) o la narcolepsia. Adderall se compone de equivalente cantidades de anfetaminas aspartato, el sulfato de anfetamina, la dextroanfetamina sacarato, y sulfato de dextroanfetamina.
DL-alpha-Methylphenethylamine Absorcion
Forma moléculas absorben fácilmente que son altamente solubles en lípidos
DL-alpha-Methylphenethylamine Toxicidad
LD50 = 180 mg / kg (sc, en la rata). Los síntomas de presentación más comunes observados son agitación, alucinaciones, comportamiento suicida, y dolor en el pecho.
DL-alpha-Methylphenethylamine Informacion de Pacientes
Amphetamines may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or vehicles; the patient should therefore be cautioned accordingly.
DL-alpha-Methylphenethylamine Organismos afectados
Humanos y otros mamíferos
